Free Trial

Booz Allen Hamilton (BAH) Competitors

Booz Allen Hamilton logo
$107.54 -2.89 (-2.62%)
Closing price 03:59 PM Eastern
Extended Trading
$107.52 -0.02 (-0.02%)
As of 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BAH vs. CCRN, CACI, LDOS, SAIC, CTSH, IT, DOX, EPAM, TDC, and HCKT

Should you be buying Booz Allen Hamilton stock or one of its competitors? The main competitors of Booz Allen Hamilton include Cross Country Healthcare (CCRN), CACI International (CACI), Leidos (LDOS), Science Applications International (SAIC), Cognizant Technology Solutions (CTSH), Gartner (IT), Amdocs (DOX), EPAM Systems (EPAM), Teradata (TDC), and The Hackett Group (HCKT).

Booz Allen Hamilton vs. Its Competitors

Booz Allen Hamilton (NYSE:BAH) and Cross Country Healthcare (NASDAQ:CCRN) are both business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, earnings, risk, valuation and dividends.

Booz Allen Hamilton has a beta of 0.48, indicating that its share price is 52% less volatile than the S&P 500. Comparatively, Cross Country Healthcare has a beta of 0.36, indicating that its share price is 64% less volatile than the S&P 500.

Booz Allen Hamilton has a net margin of 7.81% compared to Cross Country Healthcare's net margin of -1.41%. Booz Allen Hamilton's return on equity of 72.35% beat Cross Country Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Booz Allen Hamilton7.81% 72.35% 11.77%
Cross Country Healthcare -1.41%2.56%1.84%

Booz Allen Hamilton has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Booz Allen Hamilton, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Booz Allen Hamilton$11.98B1.11$935M$7.2514.83
Cross Country Healthcare$1.26B0.33-$14.56M-$0.53-24.11

91.8% of Booz Allen Hamilton shares are held by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are held by institutional investors. 0.9% of Booz Allen Hamilton shares are held by insiders. Comparatively, 4.9% of Cross Country Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Booz Allen Hamilton presently has a consensus target price of $134.64, suggesting a potential upside of 25.20%. Cross Country Healthcare has a consensus target price of $17.93, suggesting a potential upside of 40.30%. Given Cross Country Healthcare's higher probable upside, analysts plainly believe Cross Country Healthcare is more favorable than Booz Allen Hamilton.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Booz Allen Hamilton
2 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.17
Cross Country Healthcare
0 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Booz Allen Hamilton had 15 more articles in the media than Cross Country Healthcare. MarketBeat recorded 17 mentions for Booz Allen Hamilton and 2 mentions for Cross Country Healthcare. Booz Allen Hamilton's average media sentiment score of 1.14 beat Cross Country Healthcare's score of 0.51 indicating that Booz Allen Hamilton is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Booz Allen Hamilton
14 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cross Country Healthcare
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Booz Allen Hamilton beats Cross Country Healthcare on 14 of the 17 factors compared between the two stocks.

Get Booz Allen Hamilton News Delivered to You Automatically

Sign up to receive the latest news and ratings for BAH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BAH vs. The Competition

MetricBooz Allen HamiltonConsulting IndustryBusiness SectorNYSE Exchange
Market Cap$13.36B$7.79B$12.97B$20.46B
Dividend Yield2.02%1.62%2.68%3.72%
P/E Ratio14.8325.8728.6727.84
Price / Sales1.112.9239.8850.06
Price / Cash14.0818.2126.0718.22
Price / Book13.586.246.234.58
Net Income$935M$272.15M$188.58M$982.91M
7 Day Performance0.21%2.85%3.88%1.41%
1 Month Performance4.29%0.25%4.25%4.97%
1 Year Performance-30.02%2.08%37.48%14.19%

Booz Allen Hamilton Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BAH
Booz Allen Hamilton
4.9248 of 5 stars
$107.54
-2.6%
$134.64
+25.2%
-27.6%$13.36B$11.98B14.8335,800Positive News
CCRN
Cross Country Healthcare
3.8488 of 5 stars
$13.05
+2.0%
$17.93
+37.4%
-5.1%$427.78M$1.34B-24.628,205
CACI
CACI International
2.9417 of 5 stars
$476.95
+2.9%
$520.31
+9.1%
+19.7%$10.49B$7.66B22.5124,000Analyst Upgrade
LDOS
Leidos
4.4184 of 5 stars
$157.94
+1.5%
$177.46
+12.4%
+13.0%$20.33B$16.66B15.8945,000Positive News
Analyst Upgrade
SAIC
Science Applications International
3.8045 of 5 stars
$112.61
+3.1%
$124.73
+10.8%
+2.9%$5.28B$7.51B18.9926,000News Coverage
Positive News
Dividend Announcement
High Trading Volume
CTSH
Cognizant Technology Solutions
4.6401 of 5 stars
$78.03
+0.4%
$85.00
+8.9%
+18.3%$38.46B$19.74B16.43355,300Positive News
IT
Gartner
4.7278 of 5 stars
$403.99
+0.3%
$515.89
+27.7%
-11.7%$31.10B$6.30B25.1419,500
DOX
Amdocs
4.881 of 5 stars
$91.24
+0.8%
$105.33
+15.4%
+17.0%$10.30B$5.00B19.2129,058Analyst Forecast
EPAM
EPAM Systems
4.9754 of 5 stars
$177.28
+1.3%
$233.93
+32.0%
-2.2%$10.04B$4.73B24.7961,200
TDC
Teradata
3.8392 of 5 stars
$22.37
+2.1%
$27.25
+21.8%
-33.0%$2.14B$1.75B15.755,700Positive News
HCKT
The Hackett Group
3.497 of 5 stars
$25.42
+1.0%
$31.33
+23.3%
+20.1%$703.12M$313.86M29.911,478Positive News
Analyst Downgrade

Related Companies and Tools


This page (NYSE:BAH) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners